Investor Presentaiton
The Wound & Skin Care 2025 strategic plan
Scale our China business
by strengthening our commercial
foundation and accelerate in silicone
with 3DFit Technology
Scale our US business
in Acute channel with 3DFit
Technology and maximise potential
Wound & Skin Care portfolio
Geographies
Strategic enablers
Lead with 3DFit Technology
through new marketing and portfolio
initiatives
Launch new pipeline
Including Biatain Fiber to close
portfolio gaps and ensure strong
lifecycle management
75
75
US
Wound & Skin Care
China
EU
Strive
25
SUSTAINABLE
Emerging
markets
3DFit
Technology
GROWTH
LEADERSHIP
3DFit
Technology
Acceleration
Pipeline
Margin uplift
Build on positive momentum in EU
in silicone and 3DFit Technology and
increase share of voice in selected
markets
Accelerate growth in key EM markets
by investing in specific local opportunities
Further growth
Seek for acceleration
by exploring inorganic opportunities
Margin uplift
Optimise sales mix and product
profitability
ColoplastView entire presentation